# Comparison of a Novel Leuprolide With Market Leuprolide

> **NCT03662958** · NA · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 48 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Lutrate
- **DRUG:** Enantone

## Key facts

- **NCT ID:** NCT03662958
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03662958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03662958, "Comparison of a Novel Leuprolide With Market Leuprolide". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03662958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*